Ella Easterling , APRN
Nurse Practitioner • Oklahoma City, OK
6100 S Walker Ave
Oklahoma City, OK 731397026
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Ella Easterling is listed in NPPES under Nurse Practitioner.
-
NPI assigned on June 27, 2018; this date does not establish years in practice.
-
Published CMS data list 1,563 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Quetiapine Fumarate — 146 prescription fills, including refills.
- Buspirone Hcl — 107 prescription fills, including refills.
- Trazodone Hcl — 83 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 40 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 90% of clinicians listed under Nurse Practitioner in Oklahoma City, OK (2024, 74 clinicians with data). Median for this group: 170. Middle half: 40 to 592.
More Part D prescriptions than 75% of clinicians listed under Nurse Practitioner in Oklahoma (2024, 355 clinicians with data). Median for this group: 400. Middle half: 111 to 1,347.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 2,789 in 2020 to 1,563 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
6100 S Walker Ave
Oklahoma City, OK 731397026
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
2017
What Public CMS Data Show
Nurse Practitioner: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
2,832 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$358,514 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $297.43 across 14 records.
By nature of payment
- Food and Beverage: $297.43 across 14 records.
Reporting-company totals (3 largest of 8)
- Otsuka America Pharmaceutical, Inc.: $71.52 across 3 records.
- ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.): $67.50 across 3 records.
- Janssen Pharmaceuticals, Inc: $53.50 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
9 years (graduated 2017)
CMS Doctors and Clinicians data list 2017 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2018
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
May accept Medicare assignment
CMS data show this clinician may accept Medicare assignment. Clinicians who do not always accept assignment can decide case by case.
Ask the office before your visit. If a clinician does not accept assignment for a service, they can charge up to 15% more than the Medicare-approved amount, and you may be asked to pay the full amount at the visit.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Ella Easterling has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Ella Easterling as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Oklahoma City and Oklahoma
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Nurse Practitioner in Oklahoma City, OK (2024, 74 clinicians with data). Median for this group: 170. Middle half: 40 to 592.
More Part D prescriptions than 75% of clinicians listed under Nurse Practitioner in Oklahoma (2024, 355 clinicians with data). Median for this group: 400. Middle half: 111 to 1,347.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Nurse Practitioner in Oklahoma City, OK (2024, 74 clinicians with data). Median for this group: $7,217. Middle half: $635 to $81,121.
A higher Part D drug cost than 85% of clinicians listed under Nurse Practitioner in Oklahoma (2024, 355 clinicians with data). Median for this group: $23,008. Middle half: $2,002 to $147,974.
176 active clinicians are listed under Nurse Practitioner with a practice address in Oklahoma City, OK (716 in Oklahoma).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Oklahoma City
17.6% of these 176 clinicians have the CMS telehealth indicator.
46.6% of these 176 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 44% from 2,789 in 2020 to 1,563 in 2024.
- 2020: 2,789
- 2021: 2,699
- 2022: 2,632
- 2023: 1,774
- 2024: 1,563
-
30-day fills
30-day fills decreased 17% from 3,431 in 2020 to 2,832 in 2024.
- 2020: 3,431
- 2021: 3,307
- 2022: 3,294
- 2023: 2,864
- 2024: 2,832
-
Part D drug cost
Part D drug cost decreased 33% from $538,761 in 2020 to $358,514 in 2024.
- 2020: $538,761
- 2021: $520,871
- 2022: $645,996
- 2023: $445,742
- 2024: $358,514
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 87% from $2,221.21 in 2021 to $297.43 in 2025.
- 2021: $2,221.21
- 2022: $1,433.89
- 2023: $485.53
- 2024: $563.31
- 2025: $297.43
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 14 records totaling $297.43.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $30.20 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
TRINTELLIX | General | $29.60 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
FANAPT | General | $24.39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $23.76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $23.11 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $20.95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $20.63 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
ABILIFY MAINTENA | General | $20.37 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
INVEGA SUSTENNA | General | $19.79 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
INVEGA SUSTENNA | General | $17.98 |
| Neurocrine BioSciences, Inc. |
Food and Beverage
In-kind items and services
|
INGREZZA | General | $17.30 |
| Teva Pharmaceuticals USA, Inc. |
Food and Beverage
In-kind items and services
|
UZEDY | General | $17.02 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
COBENFY | General | $16.60 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
INVEGA SUSTENNA | General | $15.73 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Quetiapine Fumarate | Quetiapine Fumarate | 146 | 8,895 | $4,096.41 | 57 |
| Buspirone Hcl | Buspirone Hcl | 107 | 6,670 | $2,585.61 | 39 |
| Trazodone Hcl | Trazodone Hcl | 83 | 4,800 | $620.16 | 37 |
| Propranolol Hcl | Propranolol Hcl | 70 | 3,655 | $1,532.77 | 37 |
| Risperidone | Risperidone | 64 | 3,997 | $915.88 | 26 |
| Lurasidone Hcl | Lurasidone Hcl | 64 | 4,088 | $6,908.61 | 33 |
| Aripiprazole | Aripiprazole | 63 | 4,051 | $1,844.71 | 27 |
| Sertraline Hcl | Sertraline Hcl | 59 | 3,090 | $354.41 | 22 |
| Fluoxetine Hcl | Fluoxetine Hcl | 55 | 3,554 | $277.97 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 49 | 2,834 | $1,338.50 | 21 |
| Olanzapine | Olanzapine | 46 | 2,270 | $901.29 | 22 |
| Prazosin Hcl | Prazosin Hcl | 43 | 2,130 | $919.17 | 15 |
| Vraylar | Cariprazine Hcl | 42 | 1,320 | $62,917.98 | — |
| Alprazolam | Alprazolam | 41 | 1,230 | $148.22 | 15 |
| Gabapentin | Gabapentin | 40 | 1,768 | $383.89 | — |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 37 | 2,084 | $1,747.76 | 18 |
| Doxepin Hcl | Doxepin Hcl | 36 | 1,957 | $1,880.05 | 17 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 35 | 2,107 | $1,677.19 | 12 |
| Invega Sustenna | Paliperidone Palmitate | 33 | 924 | $105,249.59 | — |
| Bupropion Xl | Bupropion Hcl | 32 | 2,040 | $729.83 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 31 | 2,070 | $190.20 | 15 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 31 | 1,530 | $1,650.45 | — |
| Mirtazapine | Mirtazapine | 30 | 1,904 | $1,359.90 | 15 |
| Clonidine Hcl | Clonidine Hcl | 29 | 1,770 | $225.67 | 14 |
| Escitalopram Oxalate | Escitalopram Oxalate | 27 | 1,530 | $181.42 | 11 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 363L00000X
(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20251111003870
OK
5597256198
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Psychiatry & Neurology - Psychiatry
Doctor of Medicine (M.D.)
Nurse Practitioner - Psychiatric/Mental Health
Nurse Practitioner - Psychiatric/Mental Health
Psychiatric-Mental Health Nurse Practitioner (Board Certified), Family Nurse Practitioner (Board Certified)
Career & Practice History
NPI enumerated June 27, 2018.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from July 2018 to November 2026.
NPI Administrative Meta
Other Nurse Practitioners in Oklahoma City
- Michelle Johnson, APRN
- Mackenzie Nolan, NP
- Rachel Wayland, DNP-APRN
- Samina Zafar
- Taylor Della Vecchio, APRN
- Jacqueline Yarbrough, FNP-C
Mailing Address
900 Ne 122nd St Apt 1410
Oklahoma City, OK 731149211
Phone: 4054109531